DUSP13A
Dual specificity protein phosphatase 13A
Also known as: BEDP, DS13A_HUMAN, DUSP13, DUSP13B, FLJ32450, MDSP, TMDP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6B8I1
- Gene
- DUSP13A
- Ensembl
- ENSG00000079393
- Chromosome
- 10
- Canonical length
- 188 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Members of the protein-tyrosine phosphatase superfamily cooperate with protein kinases to regulate cell proliferation and differentiation. This gene encodes a dual specificity phosphatase that acts on both phosphotyrosine and phosphoserine/threonine residues. The encoded protein is expressed in testis. [provided by RefSeq, Mar 2023]
Canonical amino-acid sequenceUniProt
188 residues, UniProt reviewed canonical sequence.
>Q6B8I1|DUSP13A
1 MAETSLPELG GEDKATPCPS ILELEELLRA GKSSCSRVDE VWPNLFIGDA ATANNRFELW
61 KLGITHVLNA AHKGLYCQGG PDFYGSSVSY LGVPAHDLPD FDISAYFSSA ADFIHRALNT
121 PGAKVLVHCV VGVSRSATLV LAYLMLHQRL SLRQAVITVR QHRWVFPNRG FLHQLCRLDQ
181 QLRGAGQSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DUSP13A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 241 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 241 nTPM
- tongue: 104 nTPM
- testis: 51 nTPM
- heart muscle: 15 nTPM
- bone marrow: 5.6 nTPM
- esophagus: 3.2 nTPM
Single-cell type
- early spermatids: 442 nCPM
- late primary spermatocytes: 266 nCPM
- myonuclei: 141 nCPM
- late spermatids: 83 nCPM
- thymic myoid cells: 35 nCPM
- neutrophil progenitors: 20 nCPM
Immune cell
- neutrophil: 1.4 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- pons: 3.2 nTPM
- midbrain: 0.9 nTPM
- hypothalamus: 0.5 nTPM
- cerebral cortex: 0.4 nTPM
- basal ganglia: 0.2 nTPM
- medulla oblongata: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.29
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- phosphatase activity
- protein serine/threonine phosphatase activity
- protein tyrosine phosphatase activity
- protein tyrosine/serine/threonine phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dual specificity phosphatase, catalytic domain
- Tyrosine-specific protein phosphatases domain
- Protein-tyrosine phosphatase, catalytic
- Protein-tyrosine phosphatase, active site
- Atypical dual specificity phosphatase, subfamily A
- Dual specificity protein phosphatase domain
- Protein-tyrosine phosphatase-like
- Dual specificity phosphatase, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DUSP13A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DUSP13A as an antibody target. Whether an autoantibody or antibody against DUSP13A could matter depends on whether native DUSP13A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DUSP13A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DUSP13A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...